ExecMind is pleased to return as a partner of the LSBC Central European Life Science Investment Conference, taking place in Kraków on 21–23 October 2026.
As a Krakow-based firm working across the European life sciences sector, we are particularly pleased to welcome international founders, investors and senior leaders to our home city.
Now in its 13th edition, LSBC retains an intimate format: around 120 delegates coming together for focused conversations about investing in and building life sciences companies in Central Europe. This setting creates space for meaningful exchanges and relationships that extend beyond the conference.
This year’s programme places AI at the centre of the discussion, exploring its implications for investment strategy, exit dynamics, intellectual property, drug discovery and capital efficiency.
These questions connect directly with our work at ExecMind. As companies change how they discover, develop and commercialise innovations, their leadership needs evolve too. For founders, investors and boards, understanding which capabilities are needed and when to bring them into the business is an important part of preparing for the next stage of growth.
If you are attending, we would be delighted to find time over coffee to discuss your company’s plans, portfolio priorities or leadership challenges.
We look forward to welcoming the LSBC community to Kraków.
